Human immunodeficiency virus (HIV) is the etiological agent of acquired immunodeficiency
syndrome (AIDS). Nowadays, FDA has approved over thirty antiretroviral drugs grouped in …

Infectious diseases have been evolving and re-evolving over the ages and causing
immense misery to humans. Among them, some have been prevented and eradicated, but …

Background Long-acting injectable cabotegravir pre-exposure prophylaxis (PrEP) is
recommended by WHO as an additional option for HIV prevention in sub-Saharan Africa, but …

Objective The purpose of this study is to investigate the incidence of determinants for
virologic failure and to identify predisposing factors to enhance treatment efficacy. Tackling …

Despite the proven virological advantages, there remains some controversy regarding
whether first-line integrase strand transfer inhibitors (INSTIs)-based antiretroviral therapy …

Introduction The development of long-acting (LA) drugs has changed the management of
common medical conditions for human replication immunodeficiency virus (HIV). Cabenuva …

Antiretroviral therapies (ARTs) have revolutionized the management of human
immunodeficiency virus (HIV) infection, significantly improved patient outcomes, and …

Nowadays, the selective introduction of fluorine into bioactive compounds is a mature
strategy in the design of drugs allowing to increase efficiency, biological half-life and bio …

Objectives Real-world experience with coformulated bictegravir, emtricitabine, and tenofovir
alafenamide (BIC/FTC/TAF) is sparse as a switch regimen among people living with HIV …

Cannabis sativa is a plant used for recreational and therapeutic purposes; however, many of
the secondary metabolites in the plant have not been thoroughly investigated. Stilbenes are …